Individualized treatment plans for patients

The Neuroscience Institute at Baylor Scott & White Medical Center – Temple offers the complete spectrum of diagnostics and treatment. With specialists from neurology, neurosurgery, neuro-oncology, neuropsychology and neurointerventional surgery, we offer advanced and individualized treatment plans for patients.

Treatment and services

Brain and Spine Tumor Program

The Baylor Scott & White Neuroscience Institute offers expert care for patients battling tumors of the brain and spine. In collaboration with the Baylor Scott & White Cancer Institute, the Brain and Spine Tumor Program provides advanced treatment for patients with brain tumors and neurologic complications of cancer.

Our Temple brain and spine tumor program team includes:

  • Neurologists
  • Neurosurgeons
  • Neuro-oncologists
  • Radiation oncologists
  • Surgical oncologists
Most brain and spine tumor patients will be seen in the Baylor Scott & White Vasicek Cancer Treatment Center – Temple on the Temple campus. There, they meet with a team of physicians to determine the best treatment options.

Achievements

Baylor Scott & White Medical Center – Temple's Comprehensive Stroke Center achievements include:

  • 2024 American Heart Association / American Stroke Association Get with The Guidelines Stroke Gold Plus designation, recognizing demonstrated performance for 24 or more consecutive months
  • 2024 recipient of Target Stroke Honor Roll Elite Award (American Heart Association / American Stroke Association) and Type 2 Diabetes Honor Roll Award
  • To earn this award, clot-busting (thrombolytic) medication must be delivered within 60 minutes to at least 85% of acute ischemic stroke patients.
  • In 2023, the median time for administering clot-busting medication was 39 minutes, with 96.7% of patients receiving it within 60 minutes of arriving in the emergency department and 86% of patients receiving it within 45 minutes
  • 97.8% compliance with all American Heart Association / American Stroke Association Stroke Measures in 2023
  • In 2023, 93 patients were treated with clot-busting medication, and 53 patients were treated with mechanical endovascular reperfusion therapy
  • 2023 demonstrated 4% serious complication rate for symptomatic patients that have had a carotid endarterectomy or carotid stenting procedure and 0% serious complication rate for asymptomatic patients that have had a carotid endarterectomy or carotid stenting procedure at Baylor Scott & White Medical Center – Temple. This rate is below the benchmark set forth by The Joint Commission
  • Serious complications can include stroke, death or heart attack after the procedure
  • To minimize the stroke risk, a provider may recommend the patient has a carotid endarterectomy or carotid stenting procedure to restore blood flow in the neck artery and to the brain